30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Atkinson Edward Morrow III

Track

Insider profile

Atkinson Edward Morrow III's trades of Vertex Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-26 2026-02-25
PlS Planned sale
60,094 +12.5%
493.20
US$2,359,035 		60,094 +12.5% 493.20 US$2,359,035
2026-02-25 2026-02-25
PrS Proposed sale
1,155
78.71
US$3,863,567 		1,155 78.71 US$3,863,567
2026-02-19 2026-02-18
PlS Planned sale
33,309 +15.9%
24.17
US$2,523,367 		33,309 +15.9% 24.17 US$2,523,367
2026-02-18 2026-02-18
PrS Proposed sale
817
473.68
US$386,997 		817 473.68 US$386,997
2026-02-19 2026-02-17
PlS Planned sale
2,031 -8.6%
489.46
US$994,093 		2,031 -8.6% 489.46 US$994,093
2026-02-17 2026-02-17
PrS Proposed sale
2,031
489.46
US$994,093 		2,031 489.46 US$994,093
2026-02-12 2026-02-11
PlS Planned sale
1,751 -7.4%
460.43
US$806,213 		1,751 -7.4% 460.43 US$806,213
2026-02-11 2026-02-11
PrS Proposed sale
1,751
460.43
US$806,213 		1,751 460.43 US$806,213
2025-11-19 2025-11-17
PlS Planned sale
2,500 -12.9%
434.58
US$1,086,450 		2,500 -12.9% 434.58 US$1,086,450
2025-11-17 2025-11-17
PrS Proposed sale
2,500
434.58
US$1,086,450 		2,500 434.58 US$1,086,450
2025-02-28 2025-02-27
PlS Planned sale
2,650 -12.0%
475.34
US$1,259,651 		2,650 -12.0% 475.34 US$1,259,651
2025-02-27 2025-02-27
PrS Proposed sale
2,650
475.34
US$1,259,651 		2,650 475.34 US$1,259,651
2025-02-26 2025-02-25
PlS Planned sale
1,767 -6.7%
480.95
US$849,839 		1,767 -6.7% 480.95 US$849,839
2025-02-25 2025-02-25
PrS Proposed sale
1,767
480.95
US$849,839 		1,767 480.95 US$849,839
2025-02-12 2025-02-11
PlS Planned sale
1,747 -7.0%
459.83
US$803,323 		1,747 -7.0% 459.83 US$803,323
2025-02-11 2025-02-11
PrS Proposed sale
1,747
459.83
US$803,323 		1,747 459.83 US$803,323
2024-06-13 2024-06-12
PlS Planned sale
7,288 -31.3%
478.00
US$3,483,664 		7,288 -31.3% 478.00 US$3,483,664
2024-06-12 2024-06-12
PrS Proposed sale
7,288
478.00
US$3,483,664 		7,288 478.00 US$3,483,664
2024-02-27 2024-02-26
PlS Planned sale
883 -5.2%
425.70
US$375,893 		883 -5.2% 425.70 US$375,893
2024-02-26 2024-02-26
PrS Proposed sale
883
425.70
US$375,893 		883 425.70 US$375,893
2024-02-23 2024-02-21
PlS Planned sale
1,201 -6.1%
421.77
US$506,546 		1,201 -6.1% 421.77 US$506,546
2024-02-21 2024-02-21
PrS Proposed sale
1,201
421.77
US$506,546 		1,201 421.77 US$506,546
2024-02-21 2024-02-20
PlS Planned sale
801 -3.9%
420.79
US$337,053 		801 -3.9% 420.79 US$337,053
2024-02-20 2024-02-20
PrS Proposed sale
801
420.79
US$337,053 		801 420.79 US$337,053
2024-02-13 2024-02-12
PlS Planned sale
913 -3.8%
420.24
US$383,679 		913 -3.8% 420.24 US$383,679
2024-02-12 2024-02-12
PrS Proposed sale
913
420.24
US$383,679 		913 420.24 US$383,679
2023-06-05 2023-06-01
US 89Bio Inc (ETNB)
PlS Planned sale
6,250 -100.0%
17.91
US$111,938 		6,250 -100.0% 17.91 US$111,938
2023-06-01 2023-06-01
US 89Bio Inc (ETNB)
PrS Proposed sale
6,250
17.91
US$111,961 		6,250 17.91 US$111,961
2023-03-03 2023-03-01
US 89Bio Inc (ETNB)
PlS Planned sale
10,000 -100.0%
13.60
US$136,000 		10,000 -100.0% 13.60 US$136,000